ClinicalTrials.gov
public full text
Public Domain
First-in-human, Single Ascending Dose Study of CEL383 in Healthy Adult Subjects
This is a first-in-human, randomized, double-blind, placebo-controlled, single ascending dose study to evaluate the safety, tolerability, and pharmacokinetics of CEL383 in healthy volunteers.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Efecto de la aplicación de cuatro dosis de aminoácido en el rendimiento de cebolla (Allium cepa L.) variedad Sivan en condiciones de La Yarada Los Palos#1068401
- Bioequivalence Study of Apixaban Tablets in Healthy Chinese Subjects#811954
- The PK/PD Study of Single Dose of SHR3824 in Healthy Volunteers#300372
- Clinical Trial to Compare the Pharmacokinetics and Safety of Eperisone HCl SR Tablet 75mg and Myonal Tablet 50mg#966836
- A Bioequivalence Study of CT-L01 Compared to Co-administration (ALO 25 mg and MET XR 1,000 mg) in Healthy Volunteers#481728
Record · ID 907060
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive